Pharming Group N.V. Archives

Browsing: Pharming Group N.V.

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Health August 9, 2023

Single-arm Phase III study in Japan evaluating leniolisib in patients aged 12 years and older with APDS, a rare primary…

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

Technology July 18, 2023

LEIDEN, The Netherlands, July 18, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces…

Pharming annonce l'approbation par la FDA américaine de Joenja® (leniolisib) comme premier et unique traitement indiqué pour l'APDS

Health March 28, 2023

L’APDS (syndrome de la phosphoinositide 3-kinase delta activée (PI3Kδ)) est une immunodéficience primaire rare et progressive Joenja® est un traitement ciblé…

Pharming gibt die Zulassung von Joenja® (Leniolisib) durch die US-amerikanische Gesundheitsbehörde FDA als erste und einzige Behandlung für APDS bekannt

Health March 26, 2023

APDS (aktivierte Phosphoinositid-3-Kinase delta (PI3Kδ) Syndrom) ist eine seltene und fortschreitende primäre Immundefizienz Joenja® ist eine gezielte Behandlung von APDS…

Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement

Health March 13, 2023

LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) is aware that…

Pharming anuncia primeiro paciente inscrito em ensaio clínico pediátrico de leniolisibe

Health February 21, 2023

O estudo multinacional de Fase III está avaliando comprimidos de leniolisibe em crianças de 4 a 11 anos com APDS,…

What's Hot

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Browsing: Pharming Group N.V.

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

Pharming annonce l'approbation par la FDA américaine de Joenja® (leniolisib) comme premier et unique traitement indiqué pour l'APDS

Pharming gibt die Zulassung von Joenja® (Leniolisib) durch die US-amerikanische Gesundheitsbehörde FDA als erste und einzige Behandlung für APDS bekannt

Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement

Pharming anuncia primeiro paciente inscrito em ensaio clínico pediátrico de leniolisibe

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

smartBreakfast Series 2024: llamada de atención para 2027

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Must Watch

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

What's Hot

Browsing: Pharming Group N.V.

Subscribe to Updates